Serving Size: 2 Packets (1 AM Packet of 5 capsules and 1 PM Packet of 6 capsules)
Servings per Container: 30
Pill Size: #00 Veggie Cap
Vitamin A (50% as mixed carotenoids and as retinyl palmitate)
Vitamin C (as ascorbic acid)
Vitamin D3 (as cholecalciferol)
Vitamin E (as d-alpha tocopherol succinate)
Vitamin K (as phytonadione)
Vitamin K2 (as menaquinone-7; MK-7) (MenaQ7® Natural)
Thiamin (Vitamin B1; as thiamin HCl)
Riboflavin (Vitamin B2)
Niacin (as niacin and niacinamide)
Vitamin B6 (as pyridoxine HCl)
Folate (as calcium L-5-methyltetrahydrofolate) (BioFolate®)
Vitamin B12 (as methylcobalamin)
Pantothenic acid (as D-Calcium-pantothenate)
Calcium (as calcium hydroxyapatite, as dicalcium malate) (DimaCal®)
Phosphorus (from Calcium hydroxyapatite)
Iodine (from Kelp; thallus, Laminaria japonica)
Magnesium (as dimagnesium malate, as magnesium citrate, as magnesium lysinate glycinate chelate,TRAACS®)
Zinc (as zinc bisglycinate chelate; TRAACS®))
Selenium (as selenium glycinate chelate)
Copper (as copper bisglycinate chelate; TRAACS®)
Manganese (as manganeses bisglycinate chelate; TRAACS®)
Chromium (as chromium polynicotinate)
Molybdenum (as molybdenum bisglycinate chelate, TRAACS®)
Boron (as boroganic glycine)
Other Ingredients: Hypromellose, microcrystalline cellulose, vegetable magnesium stearate, silica.
Gluten Free | Dairy Free | Non-GMO
All NutriKey brand supplements are Pharmaceutical Grade and produced in Certified GMP (cGMP) facilities. All NutriKey brand supplements meet or exceed cGMP standards and are third party tested by NSF.
*Albion™, DimaCal™ and TRAACS™ are trademarks of Balchem Corp. or Albion Labs. MenaQ7®Natural is a registered trademark of NattoPharma ASA, Norway; Patents pending and granted. BioFolate® is a federally registered trademark of MTC Industries, Inc. Prod. R952 Rev. 2/20
Directions: Take 2 packets per day, taking one AM packet in the morning and one PM Packet in the evening or as recommended by your healthcare professional.
Cautions: Consult your healthcare professional if you are pregnant or nursing. Keep out of reach of children.
Warning: All forms of Vitamin K may interact with blood thinning medications. If you are taking such medications please consult with your physician before taking this product.
Store at room temperature.
Statements contained herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
1. Reginster, J Y, Deroisy, R. et al. Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. Osteoporos Int 2002; 13(12):925-931.
2. Cianferotti L, D’Asta F, Brandi ML. A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis 2013 Jun;5(3):127-39.
3. Patrick Lyn. Comparative absorption of calcium sources and calcium citrate malate prevention for osteoporosis. Altern Med Review 1999;4(2):74-85.
4. Moshfegh A, Goldman J, Ahuja J, Rhodes D, LaComb R. 2009. What We Eat in America, NHANES 2005-2006: Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium. U.S. Department of Agriculture, Agricultural Research Service.
5. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001; 56(2): 163-70.
6. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993; 6:155-163.
7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-26.
8. Wamberg L, Pedersen SB, Richelsen B, Rejnmark L. The effect of high-dose vitamin d supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlledstudy. Calcif Tissue Int 2013 Jul;93(1):69-77.
9. Cauley JA, Lacroix AZ, Wu L, Horwitz M, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008 Aug 19;149(4):242-50.
10. Weber P. Management of osteoporosis: is there a role for vitamin K? Int J Vitam Nutr Res 997;67(5):350-6.
11. Braam LA, Knapen MH et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003 Jul;73(1):21-6.
12. Nielson FH. Boron: an overlooked element of potential nutritional importance. Nutr Today 1988;Jan/Feb:4-7.
13. Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res 1998 Winter;66(1-3):319-30.
14. Strause l, Saltman P, Smith KT, et al. Spical bon eloss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060:1064.